Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00456300 · ClinicalTrials.gov registry record · Phase 2
Role of Exenatide in Type 1 Diabetes
A Phase 2 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 11
- Enrollment target
NCT00456300 is a Phase 2 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 11 participants.
The verdict
NCT00456300, a Phase 2 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to see if giving exenatide and insulin before a meal would lower blood sugars after the meal. This study may help in developing new treatments to help control high blood sugars after meals. This may help improve overall blood sugar control and prevent the long-term effects of diabetes.
Interventions
- DRUG Insulin
- DRUG Exenatide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2007-03 |
| Est. Completion | 2009-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00456300
The ClinicalTrials.gov registry entry for NCT00456300 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Insulin is the first listed.
NCT00456300 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00456300 about?
NCT00456300 is a clinical study titled "Role of Exenatide in Type 1 Diabetes". The purpose of this study is to see if giving exenatide and insulin before a meal would lower blood sugars after the meal. This study may help in developing new treatments to help control high blood sugars after meals. This may help improve overall blood sugar control and prevent the long-term effec...
What is the current status of trial NCT00456300?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 11 participants. The study started on 2007-03. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00456300?
The interventions under investigation include: Insulin (DRUG), Exenatide (DRUG).
Who is sponsoring clinical trial NCT00456300?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.